Zampaletta C - Search Results

1

Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.

Tursi A, Mocci G, Allegretta L, Aragona G, Bianco MA, Colucci R, Cuomo A, Della Valle N, Ferronato A, Forti G, Gaiani F, Giorgetti G, Graziani MG, Lofano K, Lorenzetti R, Larussa T, Penna A, Pica R, Pranzo G, Rodino' S, Scarcelli A, Zampaletta C, Bassotti G, Cazzato AI, Chiri S, Clemente V, Cocco A, De' Angelis G, Donnarumma L, Faggiani R, Graziosi C, Le Grazie M, Luzza F, Meucci C, Monterubbianesi R, Pagnini C, Perazzo P, Picchio M, Sacco R, Sebkova L, Serio M, Napolitano D, Pugliese D, Scaldaferri F, Schiavoni E, Turchini L, Armuzzi A, Elisei W, Maconi G, Papa A. Tursi A, et al. Among authors: zampaletta c. Inflamm Bowel Dis. 2023 Mar 1;29(3):376-383. doi: 10.1093/ibd/izac092. Inflamm Bowel Dis. 2023. PMID: 35579320

2

Spontaneous right ventricular thrombus in a patient with active ulcerative colitis and protein C deficiency: a review with a case report.

Urgesi R, Zampaletta C, Masini A, Pelecca G, Pastorelli A, De Lorenzo A, Faggiani R. Urgesi R, et al. Among authors: zampaletta c. Eur Rev Med Pharmacol Sci. 2010 May;14(5):455-63. Eur Rev Med Pharmacol Sci. 2010. PMID: 20556925 Review.

3

Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients.

Urgesi R, Pelecca G, Cianci R, Masini A, Zampaletta C, Riccioni ME, Faggiani R. Urgesi R, et al. Among authors: zampaletta c. Can J Gastroenterol. 2011 Jun;25(6):315-8. doi: 10.1155/2011/967671. Can J Gastroenterol. 2011. PMID: 21766091 Free PMC article.

4

Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Eur J Intern Med. 2014 Jun;25(5):485-90. doi: 10.1016/j.ejim.2014.02.010. Epub 2014 Mar 13. Eur J Intern Med. 2014. PMID: 24631020

5

Letter: diverticulosis in inflammatory bowel diseases.

Tursi A, Elisei W, Picchio M, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Aliment Pharmacol Ther. 2014 Apr;39(8):899-900. doi: 10.1111/apt.12656. Aliment Pharmacol Ther. 2014. PMID: 24635315 Free article. No abstract available.

6

Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

Tursi A, Elisei W, Picchio M, Zampaletta C, Pelecca G, Faggiani R, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Tech Coloproctol. 2014 Nov;18(11):1041-6. doi: 10.1007/s10151-014-1177-1. Epub 2014 Jun 12. Tech Coloproctol. 2014. PMID: 24915941 Clinical Trial.

7

Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease.

Tursi A, Elisei W, Picchio M, Zampaletta C, Faggiani R, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Aliment Pharmacol Ther. 2014 Jul;40(2):218-20. doi: 10.1111/apt.12828. Aliment Pharmacol Ther. 2014. PMID: 24946069 Free article. No abstract available.

8

Managing ambulatory ulcerative colitis patients with infliximab: a long term follow-up study in primary gastroenterology centers.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Eur J Intern Med. 2014 Oct;25(8):757-61. doi: 10.1016/j.ejim.2014.07.007. Epub 2014 Jul 30. Eur J Intern Med. 2014. PMID: 25086677

9

Effectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first "real-life" experience in primary gastroenterology centers in Italy.

Tursi A, Elisei W, Picchio M, Penna A, Forti G, Giorgetti GM, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G. Tursi A, et al. Among authors: zampaletta c. Ann Gastroenterol. 2014;27(4):369-373. Ann Gastroenterol. 2014. PMID: 25331091 Free PMC article.

10

Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classification.

Tursi A, Brandimarte G, Di Mario F, Andreoli A, Annunziata ML, Astegiano M, Bianco MA, Buri L, Cammarota G, Capezzuto E, Chilovi F, Cianci M, Conigliaro R, Del Favero G, Di Cesare L, Di Fonzo M, Elisei W, Faggiani R, Farroni F, Forti G, Germanà B, Giorgetti GM, Giovannone M, Lecca PG, Loperfido S, Marmo R, Morucci P, Occhigrossi G, Penna A, Rossi AF, Spadaccini A, Zampaletta C, Zilli M, Zullo A, Scarpignato C, Picchio M. Tursi A, et al. Among authors: zampaletta c. Dig Dis. 2015;33(1):68-76. doi: 10.1159/000366039. Epub 2014 Dec 17. Dig Dis. 2015. PMID: 25531499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page